Search for: "Doe v. Mylan Pharmaceuticals, Inc." Results 21 - 40 of 163
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Feb 2019, 8:45 am by Lawrence B. Ebert
Mylan Pharmaceuticals Inc., No. 2018-2097 (“Valeant II”), Salix moves todisqualify in Salix Pharmaceuticals, Inc. v. [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
27 Jul 2018, 6:00 am by Kyle Kroll
Mylan Pharmaceuticals, Inc., 18-1638 (Fed. [read post]
27 Jul 2018, 6:00 am by Kyle Kroll
Mylan Pharmaceuticals, Inc., 18-1638 (Fed. [read post]
23 Jul 2018, 2:38 pm by Jason Rantanen
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
20 Jul 2018, 11:44 pm by Lawrence B. Ebert
The outcome:Mylan Pharmaceuticals, Inc., petitioned for interpartes review (“IPR”) of various patents owned by Allergan,Inc., relating to its dry eye treatment Restasis. [read post]
1 Nov 2017, 2:58 pm by Dennis Crouch
See also, 16-712bsacAAM; and  16-712 bsac America’s Health Insurance Plans;  16-712 bsac Mylan Pharmaceuticals Inc_ (“Mylan’s experiences with inter partes review highlight the pro-competitive nature of inter partes review. [read post]
12 Apr 2017, 9:52 am by Lawrence B. Ebert
(collectively, Novartis).The Board instituted IPRs on all claims of the ’283 patentbased on petitions filed by Torrent PharmaceuticalsLimited, Apotex, Inc. and Mylan Pharmaceuticals Inc. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]